The DOI matches its Crossref record; 103 of the 103 references it cites were found in a registry or an index.
A survey of current trends in computational drug repositioning
Open accessAbstract
Computational drug repositioning or repurposing is a promising and efficient tool for discovering new uses from existing drugs and holds the great potential for precision medicine in the age of big data. The explosive growth of large-scale genomic and phenotypic data, as well as data of small molecular compounds with granted regulatory approval, is enabling new developments for computational repositioning. To achieve the shortest path toward new drug indications, advanced data processing and analysis strategies are critical for making sense of these heterogeneous molecular measurements. In this review, we show recent advancements in the critical areas of computational drug repositioning from multiple aspects. First, we summarize available data sources and the corresponding computational repositioning strategies. Second, we characterize the commonly used computational techniques. Third, we discuss validation strategies for repositioning studies, including both computational and experimental methods. Finally, we highlight potential opportunities and use-cases, including a few target areas such as cancers. We conclude with a brief discussion of the remaining challenges in computational drug repositioning.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
Berman, H. M. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.1.235 · Cited by 40,196
DAVID: Database for Annotation, Visualization, and Integrated Discovery
Dennis, G., Sherman, B. T., Hosack, D. A., Yang, J., Gao, W., Lane, H. C., & Lempicki, R. A. (2003) · Genome Biology · doi:10.1186/gb-2003-4-5-p3 · Cited by 9,327
Lamb, J., Crawford, E. D., Peck, D., Modell, J. W., Blat, I. C., Wrobel, M. J., Lerner, J., Brunet, J.-P., Subramanian, A., Ross, K. N., et al. (2006) · Science · doi:10.1126/science.1132939 · Cited by 5,257
How to improve R&D productivity: the pharmaceutical industry's grand challenge
Paul, S. M., Mytelka, D. S., Dunwiddie, C. T., Persinger, C. C., Munos, B. H., Lindborg, S. R., & Schacht, A. L. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3078 · Cited by 3,566
Genomic responses in mouse models poorly mimic human inflammatory diseases
Seok, J., Warren, H. S., Cuenca, A. G., Mindrinos, M. N., Baker, H. V., Xu, W., Richards, D. R., McDonald-Smith, G. P., Gao, H., Hennessy, L., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1222878110 · Cited by 3,005
Systematic identification of genomic markers of drug sensitivity in cancer cells
Garnett, M. J., Edelman, E. J., Heidorn, S. J., Greenman, C. D., Dastur, A., Lau, K. W., Greninger, P., Thompson, I. R., Luo, X., Soares, J., et al. (2012) · Nature · doi:10.1038/nature11005 · Cited by 2,456
Genetics of rheumatoid arthritis contributes to biology and drug discovery
the RACI consortium, Okada, Y., the GARNET consortium, Wu, D., Trynka, G., Raj, T., Terao, C., Ikari, K., Kochi, Y., Ohmura, K., et al. (2014) · Nature · doi:10.1038/nature12873 · Cited by 2,310
Yıldırım, M. A., Goh, K.-I., Cusick, M. E., Barabási, A.-L., & Vidal, M. (2007) · Nature Biotechnology · doi:10.1038/nbt1338 · Cited by 1,708
Predicting new molecular targets for known drugs
Keiser, M. J., Setola, V., Irwin, J. J., Laggner, C., Abbas, A. I., Hufeisen, S. J., Jensen, N. H., Kuijer, M. B., Matos, R. C., Tran, T. B., et al. (2009) · Nature · doi:10.1038/nature08506 · Cited by 1,667
Evaluating cell lines as tumour models by comparison of genomic profiles
Domcke, S., Sinha, R., Levine, D. A., Sander, C., & Schultz, N. (2013) · Nature Communications · doi:10.1038/ncomms3126 · Cited by 1,418
NCBI GEO: mining millions of expression profiles--database and tools
Barrett, T. (2004) · Nucleic Acids Research · doi:10.1093/nar/gki022 · Cited by 1,206
Denny, J. C., Bastarache, L., Ritchie, M. D., Carroll, R. J., Zink, R., Mosley, J. D., Field, J. R., Pulley, J. M., Ramirez, A. H., Bowton, E., et al. (2013) · Nature Biotechnology · doi:10.1038/nbt.2749 · Cited by 1,013
A side effect resource to capture phenotypic effects of drugs
Kuhn, M., Campillos, M., Letunic, I., Jensen, L. J., & Bork, P. (2010) · Molecular Systems Biology · doi:10.1038/msb.2009.98 · Cited by 899
PREDICT: a method for inferring novel drug indications with application to personalized medicine
Gottlieb, A., Stein, G. Y., Ruppin, E., & Sharan, R. (2011) · Molecular Systems Biology · doi:10.1038/msb.2011.26 · Cited by 881
Discovery of drug mode of action and drug repositioning from transcriptional responses
Iorio, F., Bosotti, R., Scacheri, E., Belcastro, V., Mithbaokar, P., Ferriero, R., Murino, L., Tagliaferri, R., Brunetti-Pierri, N., Isacchi, A., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1000138107 · Cited by 816
Molecular networks as sensors and drivers of common human diseases
Schadt, E. E. (2009) · Nature · doi:10.1038/nature08454 · Cited by 806
Computational Repositioning of the Anticonvulsant Topiramate for Inflammatory Bowel Disease
Dudley, J. T., Sirota, M., Shenoy, M., Pai, R. K., Roedder, S., Chiang, A. P., Morgan, A. A., Sarwal, M. M., Pasricha, P. J., & Butte, A. J. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002648 · Cited by 605
Self-citationPubMed and beyond: a survey of web tools for searching biomedical literature
Lu, Z. (2011) · Database · doi:10.1093/database/baq036 · Cited by 571
Self-citationPubTator: a web-based text mining tool for assisting biocuration
Wei, C.-H., Kao, H.-Y., & Lu, Z. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt441 · Cited by 566
Self-citationMenden, M. P., Iorio, F., Garnett, M., McDermott, U., Benes, C. H., Ballester, P. J., & Saez-Rodriguez, J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061318 · Cited by 542
Exploiting drug-disease relationships for computational drug repositioning
Dudley, J. T., Deshpande, T., & Butte, A. J. (2011) · Briefings in Bioinformatics · doi:10.1093/bib/bbr013 · Cited by 524
Self-citationGenomic responses in mouse models greatly mimic human inflammatory diseases
Takao, K., & Miyakawa, T. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1401965111 · Cited by 500
RICH, R. M., ROSENFELD, P. J., PULIAFITO, C. A., DUBOVY, S. R., DAVIS, J. L., FLYNN, H. W., GONZALEZ, S., FEUER, W. J., LIN, R. C., LALWANI, G. A., et al. (2006) · Retina · doi:10.1097/01.iae.0000225766.75009.3a · Cited by 484
DNorm: disease name normalization with pairwise learning to rank
Leaman, R., Islamaj Doğan, R., & Lu, Z. (2013) · Bioinformatics · doi:10.1093/bioinformatics/btt474 · Cited by 484
Self-citationUse of genome-wide association studies for drug repositioning
Sanseau, P., Agarwal, P., Barnes, M. R., Pastinen, T., Richards, J. B., Cardon, L. R., & Mooser, V. (2012) · Nature Biotechnology · doi:10.1038/nbt.2151 · Cited by 397
(2013) · doi:10.1158/2159-8290.cd-13-0350 · Cited by 393
Recent Advances in Drug Repositioning for the Discovery of New Anticancer Drugs
Shim, J. S., & Liu, J. O. (2014) · International Journal of Biological Sciences · doi:10.7150/ijbs.9224 · Cited by 382
Jahchan, N. S., Dudley, J. T., Mazur, P. K., Flores, N., Yang, D., Palmerton, A., Zmoos, A.-F., Vaka, D., Tran, K. Q. T., Zhou, M., et al. (2013) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-0183 · Cited by 358
Self-citationDrug repositioning: a machine-learning approach through data integration
Napolitano, F., Zhao, Y., Moreira, V. M., Tagliaferri, R., Kere, J., D’Amato, M., & Greco, D. (2013) · Journal of Cheminformatics · doi:10.1186/1758-2946-5-30 · Cited by 349
Repositioning metformin for cancer prevention and treatment
Quinn, B. J., Kitagawa, H., Memmott, R. M., Gills, J. J., & Dennis, P. A. (2013) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2013.05.004 · Cited by 281
Booth, B., & Zemmel, R. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1384 · Cited by 278
tmChem: a high performance approach for chemical named entity recognition and normalization
Leaman, R., Wei, C.-H., & Lu, Z. (2015) · Journal of Cheminformatics · doi:10.1186/1758-2946-7-s1-s3 · Cited by 268
Self-citationSystematic Drug Repositioning Based on Clinical Side-Effects
Yang, L., & Agarwal, P. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028025 · Cited by 266
Understanding PubMed(R) user search behavior through log analysis
Islamaj Dogan, R., Murray, G. C., Neveol, A., & Lu, Z. (2009) · Database · doi:10.1093/database/bap018 · Cited by 265
Self-citationDrug repositioning for personalized medicine
Li, Y. Y., & Jones, S. J. M. (2012) · Genome Medicine · doi:10.1186/gm326 · Cited by 265
Transcriptional data: a new gateway to drug repositioning?
Iorio, F., Rittman, T., Ge, H., Menden, M., & Saez-Rodriguez, J. (2013) · Drug Discovery Today · doi:10.1016/j.drudis.2012.07.014 · Cited by 237
Literature mining, ontologies and information visualization for drug repurposing
Andronis, C., Sharma, A., Virvilis, V., Deftereos, S., & Persidis, A. (2011) · Briefings in Bioinformatics · doi:10.1093/bib/bbr005 · Cited by 234
Khatri, P., Roedder, S., Kimura, N., De Vusser, K., Morgan, A. A., Gong, Y., Fischbein, M. P., Robbins, R. C., Naesens, M., Butte, A. J., et al. (2013) · Journal of Experimental Medicine · doi:10.1084/jem.20122709 · Cited by 232
Self-citationSM2miR: a database of the experimentally validated small molecules’ effects on microRNA expression
Liu, X., Wang, S., Meng, F., Wang, J., Zhang, Y., Dai, E., Yu, X., Li, X., & Jiang, W. (2013) · Bioinformatics · doi:10.1093/bioinformatics/bts698 · Cited by 226
PROMISCUOUS: a database for network-based drug-repositioning
von Eichborn, J., Murgueitio, M. S., Dunkel, M., Koerner, S., Bourne, P. E., & Preissner, R. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkq1037 · Cited by 225
Xu, H., Aldrich, M. C., Chen, Q., Liu, H., Peterson, N. B., Dai, Q., Levy, M., Shah, A., Han, X., Ruan, X., et al. (2015) · Journal of the American Medical Informatics Association · doi:10.1136/amiajnl-2014-002649 · Cited by 218
Yeh, C.-T., Wu, A. T. H., Chang, P. M.-H., Chen, K.-Y., Yang, C.-N., Yang, S.-C., Ho, C.-C., Chen, C.-C., Kuo, Y.-L., Lee, P.-Y., et al. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201207-1180oc · Cited by 206
Ceribelli, M., Kelly, P. N., Shaffer, A. L., Wright, G. W., Xiao, W., Yang, Y., Griner, L. A. M., Guha, R., Shinn, P., Keller, J. M., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1411701111 · Cited by 187
The cost of new drug discovery and development.
Dickson, M., & Gagnon, J. P. (2004) · PubMed · Cited by 186
Assessing Drug Target Association Using Semantic Linked Data
Chen, B., Ding, Y., & Wild, D. J. (2012) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1002574 · Cited by 166
Self-citationThe challenges, advantages and future of phenome‐wide association studies
Hebbring, S. J. (2014) · Immunology · doi:10.1111/imm.12195 · Cited by 164
Wang, Y., Chen, S., Deng, N., & Wang, Y. (2013) · PLoS ONE · doi:10.1371/journal.pone.0078518 · Cited by 163
Computational drug repositioning through heterogeneous network clustering
Wu, C., Gudivada, R. C., Aronow, B. J., & Jegga, A. G. (2013) · BMC Systems Biology · doi:10.1186/1752-0509-7-s5-s6 · Cited by 155
Pharmaco-miR: linking microRNAs and drug effects
Rukov, J. L., Wilentzik, R., Jaffe, I., Vinther, J., & Shomron, N. (2013) · Briefings in Bioinformatics · doi:10.1093/bib/bbs082 · Cited by 153
e-Drug3D: 3D structure collections dedicated to drug repurposing and fragment-based drug design
Pihan, É., Colliandre, L., Guichou, J., & Douguet, D. (2012) · Bioinformatics · doi:10.1093/bioinformatics/bts186 · Cited by 151
Drug-Induced Regulation of Target Expression
Iskar, M., Campillos, M., Kuhn, M., Jensen, L. J., van Noort, V., & Bork, P. (2010) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1000925 · Cited by 148
Repositioning of the anthelmintic drug mebendazole for the treatment for colon cancer
Nygren, P., Fryknäs, M., Ågerup, B., & Larsson, R. (2013) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-013-1539-5 · Cited by 133
Novick, P. A., Ortiz, O. F., Poelman, J., Abdulhay, A., & Pande, V. S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0079568 · Cited by 130
Construction of Drug Network Based on Side Effects and Its Application for Drug Repositioning
Ye, H., Liu, Q., & Jia, W. P. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087864 · Cited by 130
Repositioning of an existing drug for the neglected tropical disease Onchocerciasis
Gloeckner, C., Garner, A. L., Mersha, F. B., Oksov, Y., Tricoche, N., Eubanks, L. M., Lustigman, S., Kaufmann, G. F., & Janda, K. D. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0915125107 · Cited by 107
Mining small-molecule screens to repurpose drugs
Swamidass, S. J. (2011) · Briefings in Bioinformatics · doi:10.1093/bib/bbr028 · Cited by 107
Self-citationYang, J., Li, Z., Fan, X., & Cheng, Y. (2014) · Journal of Chemical Information and Modeling · doi:10.1021/ci500340n · Cited by 102
Jin, G., Fu, C., Zhao, H., Cui, K., Chang, J. C., & Wong, S. T. C. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-2333 · Cited by 99
A new method for computational drug repositioning using drug pairwise similarity
Li, J., & Lu, Z. (2012) · IEEE International Conference on Bioinformatics and Biomedicine (BIBM) · doi:10.1109/bibm.2012.6392722 · Cited by 98
Self-citationDCDB: Drug combination database
Liu, Y., Hu, B. X., Cheng‐Xin, F. U., & Chen, X. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp697 · Cited by 97
Pathway-based drug repositioning using causal inference
Li, J., & Lu, Z. (2013) · BMC Bioinformatics · doi:10.1186/1471-2105-14-s16-s3 · Cited by 96
Self-citationShameer, K., Readhead, B., & Dudley, J. T. (2015) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026615666150112103510 · Cited by 95
MicroRNAs: regulators of cancer metastasis and epithelial-mesenchymal transition (EMT)
Ding, X. (2013) · 癌症:英文版 · doi:10.5732/cjc.013.10094 · Cited by 94
Drug Repurposing for Gastrointestinal Stromal Tumor
Pessetto, Z. Y., Weir, S. J., Sethi, G., Broward, M. A., & Godwin, A. K. (2013) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-12-0968 · Cited by 94
Hyman, D. M., Zhou, Q. C., Iasonos, A. E., Grisham, R. N., Arnold, A. G., Phillips, M. F., Bhatia, J., Levine, D. A., Aghajanian, C. A., Offit, K., et al. (2011) · Cancer · doi:10.1002/cncr.26655 · Cited by 87
DvD: An R/Cytoscape pipeline for drug repurposing using public repositories of gene expression data
Pacini, C., Iorio, F., Gonçalves, E., Iskar, M., Klabunde, T., Bork, P., & Sáez-Rodríguez, J. (2012) · Bioinformatics · doi:10.1093/bioinformatics/bts656 · Cited by 81
Jiang, W., Chen, X., Liao, M., Li, W., Lian, B., Wang, L., Meng, F., Liu, X., Chen, X., Jin, Y., et al. (2012) · Scientific Reports · doi:10.1038/srep00282 · Cited by 76
Stereoselective virtual screening of the ZINC database using atom pair 3D-fingerprints
Awale, M., Jin, X., & Reymond, J. (2015) · Journal of Cheminformatics · doi:10.1186/s13321-014-0051-5 · Cited by 76
Zhang, P., Wang, F., & Hu, J. (2014) · PubMed · Cited by 75
Vidović, D., Koleti, A., & Schürer, S. C. (2014) · Frontiers in Genetics · doi:10.3389/fgene.2014.00342 · Cited by 74
Systematic prediction of drug combinations based on clinical side-effects
Huang, H., Zhang, P., Qu, X. A., Sanseau, P., & Yang, L. (2014) · Scientific Reports · doi:10.1038/srep07160 · Cited by 73
Xu, K., & Coté, T. R. (2011) · Briefings in Bioinformatics · doi:10.1093/bib/bbr006 · Cited by 72
Network based elucidation of drug response: from modulators to targets
Iorio, F., Sáez-Rodríguez, J., & di Bernardo, D. (2013) · BMC Systems Biology · doi:10.1186/1752-0509-7-139 · Cited by 68
Computational Repositioning and Preclinical Validation of Pentamidine for Renal Cell Cancer
Zerbini, L. F., Bhasin, M., de Vasconcellos, J. F., Paccez, J. D., Gu, X., Kung, A. L., & Libermann, T. A. (2014) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0750 · Cited by 66
Systematic Drug Repurposing Through Text Mining
Tari, L., & Patel, J. H. (2014) · Methods in molecular biology · doi:10.1007/978-1-4939-0709-0_14 · Cited by 65
Zhu, Q., Tao, C., Shen, F., & Chute, C. G. (2013) · Pacific Symposium on Biocomputing (PSB) · doi:10.1142/9789814583220_0017 · Cited by 55
Stenvang, J., Kümler, I., Nygård, S. B., Smith, D. H., Nielsen, D. L., Brünner, N., & Moreira, J. M. A. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00313 · Cited by 54
Shaughnessy, A. F. (2011) · BMJ · doi:10.1136/bmj.d741 · Cited by 51
A phenome-guided drug repositioning through a latent variable model
Bişğin, H., Liu, Z., Fang, H., Kelly, R. J., Xu, X., & Tong, W. (2014) · BMC Bioinformatics · doi:10.1186/1471-2105-15-267 · Cited by 50
Wu, M., Sirota, M., Butte, A. J., & Chen, B. (2014) · Pacific Symposium on Biocomputing (PSB) · doi:10.1142/9789814644730_0008 · Cited by 49
Self-citationArighi, C. N., Wu, C. H., Cohen, K. B., Hirschman, L., Krallinger, M., Valencia, A., Lu, Z., Wilbur, J. W., & Wiegers, T. C. (2014) · Database · doi:10.1093/database/bau039 · Cited by 46
Self-citationTan, F., Yang, R., Xu, X., Chen, X., Wang, Y., Ma, H., Liu, X., Wu, X., Chen, Y., Liu, L., et al. (2014) · Molecular BioSystems · doi:10.1039/c3mb70554d · Cited by 45
LabeledIn: Cataloging labeled indications for human drugs
Khare, R., Li, J., & Lu, Z. (2014) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2014.08.004 · Cited by 44
Self-citationVencken, P. M. L. H., Kriege, M., Hooning, M., Menke‐Pluymers, M. B., Heemskerk‐Gerritsen, B. A. M., van Doorn, L. C., Collée, M. M., Jager, A., van Montfort, C., Burger, C. W., et al. (2013) · Cancer · doi:10.1002/cncr.27839 · Cited by 40 · cited 1×
“For example, the BRCA mutation (mutation in either BRCA1 or BRCA2 genes) was found to be associated with the risk of getting breast cancer for ovarian cancer patients [43].”
BackgroundScaling drug indication curation through crowdsourcing
Khare, R., Burger, J. D., Aberdeen, J. S., Tresner‐Kirsch, D., Corrales, T. J., Hirchman, L., & Lu, Z. (2015) · Database · doi:10.1093/database/bav016 · Cited by 39
Self-citationGenomics-Enabled Drug Repositioning and Repurposing
Power, A., Berger, A. C., & Ginsburg, G. S. (2014) · JAMA · doi:10.1001/jama.2014.3002 · Cited by 37
Graul, A. I., & Prous, J. R. (1998) · PubMed · Cited by 37
Systematic identification of pharmacogenomics information from clinical trials
Li, J., & Lu, Z. (2012) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2012.04.005 · Cited by 35
Self-citationMicroRNAs as predictive biomarkers and therapeutic targets in prostate cancer.
Wen, X., Deng, F., & Wang, J. (2014) · PubMed Central · Cited by 34
IDMap: facilitating the detection of potential leads with therapeutic targets
Ha, S., Seo, Y.-J., Kwon, M.-S., Chang, B.-H., Han, C.-K., & Yoon, J. (2008) · Bioinformatics · doi:10.1093/bioinformatics/btn138 · Cited by 33
A Hadoop-Based Method to Predict Potential Effective Drug Combination
Sun, Y., Xiong, Y., Xu, Q., & Wei, D. (2014) · BioMed Research International · doi:10.1155/2014/196858 · Cited by 30
Bolgár, B., Arany, Á., Temesi, G., Balogh, B., Antal, P., & Mátyus, P. (2013) · Current Topics in Medicinal Chemistry · doi:10.2174/15680266113136660164 · Cited by 26
LINKING PHARMGKB TO PHENOTYPE STUDIES AND ANIMAL MODELS OF DISEASE FOR DRUG REPURPOSING
Hoehndorf, R., Oellrich, A., Rebholz‐Schuhmann, D., Schofield, P. N., & Gkoutos, G. V. (2011) · Pacific Symposium on Biocomputing (PSB) · doi:10.1142/9789814366496_0038 · Cited by 23
Identification of Drug Combinations Containing Imatinib for Treatment of BCR-ABL+ Leukemias
Kang, Y., Hodges, A. P., Ong, E., Roberts, W. D., Piermarocchi, C., & Paternostro, G. (2014) · PLoS ONE · doi:10.1371/journal.pone.0102221 · Cited by 21
The Year's New Drugs & Biologics, 2013: Part I
Graul, A., Cruces, E., & Stringer, M. (2014) · Drugs of today · doi:10.1358/dot.2014.50.1.2116673 · Cited by 21
Liu, Z., Borlak, J. T., & Tong, W. (2014) · Genome Medicine · doi:10.1186/s13073-014-0094-2 · Cited by 20
MicroRNAs and anticancer drugs
Xing, Z., Li, D., Yang, L., Xi, Y., & Su, X. (2014) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmu003 · Cited by 19
Ng, C., Hauptman, R., Zhang, Y., Bourne, P. E., & Xie, L. (2013) · Pacific Symposium on Biocomputing (PSB) · doi:10.1142/9789814583220_0014 · Cited by 19
Experimental Confirmation of New Drug–Target Interactions Predicted by Drug Profile Matching
Végner, L., Peragovics, Á., Tombor, L., Jelinek, B., Czobor, P., Bender, A., Simon, Z., & Málnási‐Csizmadia, A. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm400813y · Cited by 16
Molineris, I., Ala, U., Provero, P., & Cunto, F. D. (2013) · BMC Bioinformatics · doi:10.1186/1471-2105-14-288 · Cited by 15
The year's new drugs & biologics, 2013: Part II
Graul, A. I., Navarro, D., Dulsat, C., et al. (2014) · Drugs of today · doi:10.1358/dot.2014.50.2.2122810 · Cited by 14
The year's new drugs and biologics, 2014: Part I
Graul, A., Cruces, E., & Stringer, M. D. (2015) · Drugs of today · doi:10.1358/dot.2015.51.1.2279964 · Cited by 14
Cited by
Opportunities and obstacles for deep learning in biology and medicine
Ching, T., Himmelstein, D. S., Beaulieu-Jones, B. K., Kalinin, A. A., Do, B. T., Way, G. P., Ferrero, E., Agapow, P.-M., Zietz, M., Hoffman, M. M., et al. (2018) · Journal of The Royal Society Interface · doi:10.1098/rsif.2017.0387 · Cited by 2,310
Self-citationModeling polypharmacy side effects with graph convolutional networks
Zitnik, M., Agrawal, M., & Leskovec, J. (2018) · Bioinformatics · doi:10.1093/bioinformatics/bty294 · Cited by 1,501
Zitnik, M., Nguyen, F., Wang, B., Leskovec, J., Goldenberg, A., & Hoffman, M. M. (2019) · Information Fusion · doi:10.1016/j.inffus.2018.09.012 · Cited by 675
Jarada, T. N., Rokne, J. G., & Alhajj, R. (2020) · Journal of Cheminformatics · doi:10.1186/s13321-020-00450-7 · Cited by 384
A review of network-based approaches to drug repositioning
Lotfi Shahreza, M., Ghadiri, N., Mousavi, S. R., Varshosaz, J., & Green, J. R. (2018) · Briefings in Bioinformatics · doi:10.1093/bib/bbx017 · Cited by 330
Metadata
- Authors
- Li, J., Zheng, S., Chen, B., Butte, A. J., Swamidass, S. J., & Lu, Z.
- Venue
- Briefings in Bioinformatics
- Publisher
- Oxford University Press (OUP)
- Published
- 2015-03-31
- Volume
- 17
- Issue
- 1
- Pages
- 2-12
- ISSN
- 1467-5463 (ISSN-L)
- 1477-4054
- OpenAlex
- W2151357092
- Cited by
- 555
- References
- 103
- FWCI
- 46.58
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.